ProSomnus Inc (NASDAQ: OSA) has completed a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital.
ProSomnus's Executive Chair, CEO, and CFO are also participating in the financing.
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Relmada Therapeutics Inc (NASDAQ: RLMD) announced efficacy results for the de novo (or new to treatment) patients (204 patients) and safety results for all subjects (627 patients) from the Phase 3 trial (Study 310) of REL-1017 in patients with